Delivery Order SPE2DR25D2206-SPE2DR26F9AR7
- Not listed
- The Defense Logistics Agency awarded a $4,168.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of developmental viscosurgical coated ophthalmic products containing 4% chondroitin. The contract is categorized as a child award under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA and represents a non-competitive set-aside transaction. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania, with...
- The Defense Logistics Agency awarded a delivery order valued at $2,426.76 to AmerisourceBergen Drug Corp for the development and supply of VSCELAS 27GA Viscoat with 4% Chondroitin on November 7, 2025. This firm fixed-price delivery order, which is set to be completed by November 10, 2025, represents a pediatric ophthalmic pharmaceutical product to be delivered to the company's corporate office location in Conshohocken, Pennsylvania. The award was made through competitive procedures with no...
- The Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order for ophthalmic irrigating solution valued at $1,808.40 under a Firm Fixed Price contract type. This non-set-aside award was executed on August 22, 2025, with an ultimate completion date of August 25, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.999 billion...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Duovisc Viscoelastic System 1.05ml, a specialized ophthalmic medical device. This firm fixed-price delivery order, valued at $18,159.03, represents a non-competitive award and is scheduled for completion by September 15, 2025. The award was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the Defense Logistics...
- The Defense Logistics Agency awarded a $6,875.82 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Viscoat syringes (0.5 mL). This competitively awarded, firm fixed-price contract with an ultimate completion date of September 3, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency valued at $5,787.81 for DUOVISC Viscoelastic System 1.05ML. The award was made on September 11, 2025, with an ultimate completion date of September 12, 2025, under a firm fixed price contract structure with no set-aside designation. This delivery order is issued against AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $15,611.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Duovisc Viscoelastic System 1.05ML, a medical ophthalmic product. The contract was competitively awarded without a set-aside designation and is scheduled for completion by August 4, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a purchase under the...
- The Defense Logistics Agency awarded a $36,631.47 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of DuoVisc Viscoelastic System 1.05ml, a specialized ophthalmic medical device used primarily in eye surgery procedures. This non-set-aside, competitively awarded contract is scheduled for completion by September 29, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award...
- The Defense Logistics Agency awarded a $8,399.34 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Duovisc Viscoelastic System 1.05ml, a medical ophthalmic product. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and is scheduled for completion by September 16, 2025. The order will be performed and fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $10,194.29 firm fixed price delivery order to AmerisourceBergen Drug Corp for DUOVISC Viscoelastic System 1.05ML, with an ultimate completion date of September 26, 2025. This competitively awarded, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime vendor agreement serves as a...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9AR7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,227.76 to AmerisourceBergen Drug Corp for the supply of ophthalmic viscoat solution containing 4% chondroitin. This firm fixed-price delivery order, issued on November 6, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 7, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant $999.999 billion IDC with DLA Troop Support Medical (contract SPE2DX) that extends through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The current delivery order for ophthalmic viscoat solution exemplifies the company's role as a critical federal medical procurement vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract mechanisms designed to meet diverse therapeutic and medical supply needs across the military healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 11/6/25 |